{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:48:09Z","timestamp":1789753689418,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2020RC3065"],"award-info":[{"award-number":["2020RC3065"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Penyanqing (PYQ), a traditional Chinese medicine (TCM), has a good clinical efficacy for the treatment of pelvic inflammatory disease (PID). Previously, researches on its anti-inflammatory effect and mechanism in vitro<jats:italic>, <\/jats:italic>in silico<jats:italic>,<\/jats:italic> and in vivo have been reported by our team. However, the interrelationship between the anti-inflammatory activity and the active compounds in PYQ are not clear. Here, the pharmacokinetics-pharmacodynamics (PK-PD) study was carried out for more proper clinical use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The plasma concentrations of salvianolic acid B (SAB), protocatechualdehyde (PRO), paeoniflorin (PE), astilbin (AST), ferulic acid (FE), and chlorogenic acid (CH) in SD rats after PYQ administration were determined by a selective and rapid HPLC\u2013MS\/MS method. In addition, the PK-PD on cell model was used to explore the relationship between the plasma concentration and inflammatory biomarkers (TNF-\u03b1, IL-1\u03b2).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results of this study showed that the six components could reach the peak blood concentration within 0.29\u00a0h, indicating the rapid absorption of it. The eliminations of AST, CH, FE, PE, and PRO were relatively fast due to their mean residence times (MRTs) within 3\u00a0h, while the elimination of SAB was slower (MRT 5.67\u2009\u00b1\u20090.66\u00a0h). Combined with a THP-1 cell model, there was a significant correlation between inflammatory factors and component plasma concentrations with correlation coefficients in the range of -0.9\u2014-0.746. Correspondingly, the drug-containing plasma obtained at 0.25\u00a0h point exhibited the best inhibition effect on production of IL-1\u03b2 and TNF-\u03b1 in LPS-induced THP-1 cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The six main components in PYQ could be quickly absorbed, and there was a potential good correlation between their pharmacokinetics and the pharmacodynamics of PYQ.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-022-03784-x","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T16:48:54Z","timestamp":1670345334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetics and pharmacodynamics of bioactive compounds in Penyanqing preparation in THP-1 inflammatory cells induced by Lipopolysaccharide"],"prefix":"10.1186","volume":"22","author":[{"given":"Linna","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishuo","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoqi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panzi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"issue":"8","key":"3784_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.disamonth.2016.03.015","volume":"62","author":"GW Ford","year":"2016","unstructured":"Ford GW, Decker C. Pelvic inflammatory disease. Dis Mon. 2016;62(8):301\u20135.","journal-title":"Dis Mon"},{"issue":"01","key":"3784_CR2","first-page":"34","volume":"25","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang D. Clinical research progress of TCM in treating pelvic inflammatory disease. Chin J Ethno. 2016;25(01):34\u20135.","journal-title":"Chin J Ethno"},{"issue":"14","key":"3784_CR3","first-page":"1339","volume":"37","author":"W Zou","year":"2017","unstructured":"Zou W, Wen X, Hu J, Xiao Z, Zheng Y. Pharmacological effects of Penyanling mixture in rats with chronic pelvic inflammatory diseases. Chin J Hosp. 2017;37(14):1339\u201342.","journal-title":"Chin J Hosp"},{"key":"3784_CR4","first-page":"440","volume":"07","author":"X Zhang","year":"1988","unstructured":"Zhang X. 102 cases of pelvic inflammatory disease treated with Penyanling. Chin J Integr Tradit West Med. 1988;07:440.","journal-title":"Chin J Integr Tradit West Med"},{"issue":"16","key":"3784_CR5","first-page":"1897","volume":"24","author":"Z Xiao","year":"2015","unstructured":"Xiao Z, Pan T, Ouyang B, Huang Y, Tian X, Wen X. HPLC fingerprints of Penyanling granules. Chin J New Drugs. 2015;24(16):1897\u2013901.","journal-title":"Chin J New Drugs"},{"key":"3784_CR6","doi-asserted-by":"publisher","first-page":"113405","DOI":"10.1016\/j.jep.2020.113405","volume":"266","author":"W Zou","year":"2021","unstructured":"Zou W, Gong L, Zhou F, Long Y, Li Z, Xiao Z, Ouyang B, Liu M. Anti-inflammatory effect of traditional Chinese medicine preparation Penyanling on pelvic inflammatory disease. J Ethnopharmacol. 2021;266:113405.","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"3784_CR7","first-page":"2879","volume":"43","author":"L Gong","year":"2021","unstructured":"Gong L, Zou W, Dong Y, Fang C, Liu M. Mechanism of Penyanling Mixture in Treating Pelvic Inflammatory Disease Based on Network Pharmacology. Chin Tradit Pat Med. 2021;43(10):2879\u201385.","journal-title":"Chin Tradit Pat Med"},{"key":"3784_CR8","first-page":"601","volume":"S1","author":"H Wang","year":"2007","unstructured":"Wang H, Shi E. The advance in the research on phamacology action of ferulic. J Inner Mongolia Univ. 2007;S1:601\u20133.","journal-title":"J Inner Mongolia Univ"},{"issue":"06","key":"3784_CR9","first-page":"115","volume":"16","author":"H Du","year":"2021","unstructured":"Du H, Lin W, Tian L. Anti-tumor Effects of Salvianolic Acid B on Colon Cancer in Rats and Its Mechanism. China J Pharm Econ. 2021;16(06):115\u201320.","journal-title":"China J Pharm Econ"},{"issue":"03","key":"3784_CR10","first-page":"788","volume":"51","author":"X Wang","year":"2020","unstructured":"Wang X, Wang Y, Zhou C, Guo H, Ma S, Wang L. Research progress on chemical constituents and pharmaco-logical effects of Salvia miltiorrhiza. Chin Tradit Herb Drugs. 2020;51(03):788\u201398.","journal-title":"Chin Tradit Herb Drugs"},{"issue":"04","key":"3784_CR11","first-page":"595","volume":"46","author":"X Lu","year":"2015","unstructured":"Lu X, Ma X, Wang J, Zhu Y, Zhou Z, Chen Z, Zhao Y, Wang J. Research progress on chemical constituents of Paeoniae Rubra Radix and their pharmacological effects. Chin Tradit Herb Drugs. 2015;46(04):595\u2013602.","journal-title":"Chin Tradit Herb Drugs"},{"issue":"02","key":"3784_CR12","first-page":"198","volume":"29","author":"C Tao","year":"2014","unstructured":"Tao C, Xuan L, Lin L. Overview of studies on the main chemical constituents and pharmacological effects of Paeoniae radix rubra. J Inner Mongolia Univ. 2014;29(02):198\u2013201.","journal-title":"J Inner Mongolia Univ"},{"issue":"24","key":"3784_CR13","first-page":"10","volume":"8","author":"S Hu","year":"2013","unstructured":"Hu S, Liu D. Determination of chlorogenic acid and hyperoside in the aerial part of angelica sinensis by HPLC. China Pract Med. 2013;8(24):10\u20131.","journal-title":"China Pract Med"},{"issue":"04","key":"3784_CR14","first-page":"12","volume":"45","author":"X Bao","year":"2017","unstructured":"Bao X. Research Progress on Quality Control of Paeoniae Rubra Radix. Guangzhou Chem Ind. 2017;45(04):12\u20133.","journal-title":"Guangzhou Chem Ind"},{"issue":"05","key":"3784_CR15","first-page":"30","volume":"45","author":"J Chen","year":"2018","unstructured":"Chen J. Determination of tanshinone II A and salvianolic acid B in traditional Chinese medicine Huiyang Solution by HPLC. Mod Salt Chem Ind. 2018;45(05):30\u20132+35.","journal-title":"Mod Salt Chem Ind"},{"issue":"09","key":"3784_CR16","first-page":"20","volume":"32","author":"Y Wang","year":"2018","unstructured":"Wang Y, Yang J, Wu G, Liu H, Liang Y, Wang Y. Simultaneous determination of coptisine, dehydrofusone and tetrahydropalmatine in Corydalis Rhizoma by RP-HPLC. Chem Eng. 2018;32(09):20\u20132.","journal-title":"Chem Eng"},{"issue":"01","key":"3784_CR17","first-page":"34","volume":"23","author":"J Xiao","year":"2013","unstructured":"Xiao J, Li Y, Chou G, Chen J. Determination of norisoboldine in Radix Linderae by UPLC. J Fujian Univ Tradit Chin Med. 2013;23(01):34\u20136.","journal-title":"J Fujian Univ Tradit Chin Med"},{"issue":"13","key":"3784_CR18","first-page":"112","volume":"42","author":"R Yuan","year":"2014","unstructured":"Yuan R, Zhao C, Xie L, Zheng M, Qin S. Determination of Ferulic Acid Content in Angelica Sinensis by HPLC. Guangzhou Chem Ind. 2014;42(13):112\u20133+151.","journal-title":"Guangzhou Chem Ind"},{"issue":"06","key":"3784_CR19","first-page":"37","volume":"19","author":"L Liu","year":"2017","unstructured":"Liu L, Duan J, Liu P, Su S, Tang Y, Qian D. Pharmacokinetic characteristics of Taohong Siwu decoction in normal and dysmenorrhea model rats. J Hubei Univ Chin Med. 2017;19(06):37\u201342.","journal-title":"J Hubei Univ Chin Med"},{"issue":"07","key":"3784_CR20","first-page":"36","volume":"14","author":"W Shan","year":"2017","unstructured":"Shan W, Xu X, Wu J. UPLC-MS\/MS determination and pharmacokinetic study of plasma concentration of Tetrahy-dropalmatine in Yuanhuzhitong Tablets. China Med Her. 2017;14(07):36\u20139.","journal-title":"China Med Her"},{"issue":"03","key":"3784_CR21","first-page":"318","volume":"20","author":"Y Wu","year":"2017","unstructured":"Wu Y, Wei X, Liu H, Dong Z. Determination of plasma concentration of indicative components in Xuanmai ganjie granules by UPLC-MS \/MS and their pharmacokinetic study. Pract Pharm Clin Rem. 2017;20(03):318\u201321.","journal-title":"Pract Pharm Clin Rem"},{"issue":"03","key":"3784_CR22","first-page":"374","volume":"33","author":"C Yang","year":"2018","unstructured":"Yang C, Cao W, Hou J, Wang W, Shi L. Research on pharmacokinetic parameters of salvianolic acid B, paeoni-florin and glycyrrhizic acid by mixed administration in rats. Northwest Pharm J. 2018;33(03):374\u20139.","journal-title":"Northwest Pharm J"},{"issue":"08","key":"3784_CR23","first-page":"808","volume":"36","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang F, Zhu M, Zhang S, Du W, Xiao X. Pharmacokinetic study of phenolic acids in rat plasma after oral administration of Qili Qiangxin Capsule. Tianjin J Tradit Chin Med. 2019;36(08):808\u201313.","journal-title":"Tianjin J Tradit Chin Med"},{"issue":"11","key":"3784_CR24","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1021\/acs.jproteome.0c00537","volume":"19","author":"RL Loo","year":"2020","unstructured":"Loo RL, Lodge S, Kimhofer T, Bong SH, Begum S, Whiley L, Gray N, Lindon JC, Nitschke P, Lawler NG, et al. Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artifact Minimization with Special Reference to COVID-19\/SARS-CoV-2 Samples. J Proteome Res. 2020;19(11):4428\u201341.","journal-title":"J Proteome Res"},{"issue":"07","key":"3784_CR25","first-page":"1025","volume":"39","author":"HZJ Tian","year":"2013","unstructured":"Tian HZJ, Mo X, Li Y, Yuan X, Li K, Huang S, He J, Chen C, Wu G. Inhibitory effect of Jianpi Xiaoji Tang drug-containing plasma on hepatocellular carcinoma HepG2 cells and its mechanism. Guangxi Medical Journal. 2013;39(07):1025\u20138.","journal-title":"Guangxi Medical Journal"},{"key":"3784_CR26","doi-asserted-by":"publisher","first-page":"113144","DOI":"10.1016\/j.jpba.2020.113144","volume":"183","author":"P Huang","year":"2020","unstructured":"Huang P, Tang Y, Li C, Zhou H, Yu L, Wan H, He Y. Correlation study between the pharmacokinetics of seven main active ingredients of Mahuang decoction and its pharmacodynamics in asthmatic rats. J Pharm Biomed Anal. 2020;183:113144.","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"3784_CR27","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3390\/molecules26071983","volume":"26","author":"YY Kuang","year":"2021","unstructured":"Kuang YY, Gao X, Niu YJ, Shi XL, Zhou W. Polymorphic Characterization, Pharmacokinetics, and Anti-Inflammatory Activity of Ginsenoside Compound K Polymorphs. Molecules. 2021;26(7):1983.","journal-title":"Molecules"},{"key":"3784_CR28","doi-asserted-by":"publisher","first-page":"114480","DOI":"10.1016\/j.jpba.2021.114480","volume":"209","author":"C Tian","year":"2022","unstructured":"Tian C, Shao Y, Jin Z, Liang Y, Li C, Qu C, Sun S, Cui C, Liu M. The protective effect of rutin against lipopolysaccharide induced acute lung injury in mice based on the pharmacokinetic and pharmacodynamic combination model. J Pharm Biomed Anal. 2022;209:114480.","journal-title":"J Pharm Biomed Anal"},{"issue":"02","key":"3784_CR29","first-page":"332","volume":"29","author":"T Luo","year":"2014","unstructured":"Luo T, Li J, Tong R. Application status and prospect of the PK-PD model in Chinese medicine research China J. Tradit. Chin Med Pharm. 2014;29(02):332\u20135.","journal-title":"Chin Med Pharm"},{"issue":"10","key":"3784_CR30","first-page":"266","volume":"17","author":"C Huang","year":"2011","unstructured":"Huang C, Lu Y, Gao X, Sun Z, Yan L. Advances of Serum Pharmacology of Chinese Medicine. Chin J Exp Tradit Med Formulae. 2011;17(10):266\u201371.","journal-title":"Chin J Exp Tradit Med Formulae"},{"issue":"1","key":"3784_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","volume":"23","author":"W Chanput","year":"2014","unstructured":"Chanput W, Mes JJ, Wichers HJ. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol. 2014;23(1):37\u201345.","journal-title":"Int Immunopharmacol"},{"key":"3784_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2018.07.001","volume":"434","author":"Y Jing","year":"2018","unstructured":"Jing Y, Sun K, Liu W, Sheng D, Zhao S, Gao L, Wei L. Tumor necrosis factor-\u03b1 promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells. Cancer Lett. 2018;434:22\u201332.","journal-title":"Cancer Lett"},{"key":"3784_CR33","unstructured":"Fei H. Changes in the distribution of serum TNF-\u03b1, IL-1\u03b2, IL-4 and T lymphocyte subsets in patients with chronic pelvic inflammatory disease. Shandong Med J. 2015; 55(38):60\u201361."},{"issue":"04","key":"3784_CR34","first-page":"583","volume":"20","author":"Q Han","year":"2016","unstructured":"Han Q. Expression and clinical significance of serum IL-1\u03b2 and THF-\u03b1 in patients with diabetic retinopathy. Chin J Lab Diagnosis. 2016;20(04):583\u20136.","journal-title":"Chin J Lab Diagnosis"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03784-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-022-03784-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03784-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T16:49:33Z","timestamp":1670345373000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-022-03784-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3784"],"URL":"https:\/\/doi.org\/10.1186\/s12906-022-03784-x","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"assertion":[{"value":"27 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Animal Ethics Committee of School of Southern Medical University. The female Sprague\u2013Dawley rats (200\u2009\u00b1\u200920\u00a0g body weight) were obtained from the Laboratory Animal Center of Southern Medical University (Guangzhou, China; Certification: SCXK-Yue-2016\u20130041). All methods were performed in accordance with the relevant guidelines and regulations when applicable. ARRIVE guidelines were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}